Wolverine Blend (BPC-157 + TB-500) COA Lookup: Verify Your Lot Number
PX1 Research provides fully transparent, lot-specific analytical documentation for every batch of lyophilisate produced. Investigators can easily verify the chemical identity, purity profile, and bioburden metrics of their research compounds by matching the physical vial lot number against our centralized digital repository.
Quick answer
PX1 Research provides fully transparent, lot-specific analytical documentation for every batch of lyophilisate produced. Investigators can easily verify the chemical identity, purity profile, and bioburden metrics of their research compounds by matching the physical vial lot number against our centralized digital repository.
Key takeaways
- In modern biochemical research, analytical integrity forms the bedrock of reproducible experimental data.
- Every physical vial of the [BPC-157 (5mg) + TB-500 (5mg) Wolverine Blend](/product/bpc-157-5mg-tb-500-5mg-wolverine-blend) manufactured by PX1 Research features an alphanumeric lot number printed directly on the primary label and secondary packaging.
- Retrieving the specific [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) (COA) for your Wolverine Blend lyophilisate requires only a few standard steps.
- High-Performance Liquid Chromatography (HPLC) is the gold standard method for determining the chemical purity and relative concentration of synthetic peptides.
Overview of Analytical Verification for the Wolverine Research Blend
In modern biochemical research, analytical integrity forms the bedrock of reproducible experimental data. When evaluating multi-component formulations such as the Wolverine Blend—a combination of body protection compound 157 (BPC-157) and thymosin beta-4 active fragment (TB-500)—principal investigators require absolute certainty regarding peptide sequence fidelity, accurate stoichiometric ratios, and structural purity. Without independent laboratory validation, extraneous synthesis side-products or micro-contaminants can alter cell culture kinetics, skew binding affinity assays, or introduce confounding variables into preclinical models.
PX1 Research enforces an uncompromising quality management system for all research peptides. Every production run undergoes rigorous third-party analytical testing prior to inventory release. By maintaining complete lot traceability from solid-phase peptide synthesis (SPPS) through lyophilization, we ensure that every laboratory receiving our reagents has immediate access to certified analytical documentation. Researchers can evaluate complete high-performance liquid chromatography (HPLC) chromatograms, mass spectrometry (MS) spectra, and endotoxin assays for their specific batch.
To review analytical documentation for any active inventory or historical batch, investigators can access our centralized COA lookup database. This open-access library provides transparent data designed to meet the compliance and documentation standards required by academic institutions, biotechnology firms, and contract research organizations (CROs).
Locating the Lot Number on Your Wolverine Blend Vial
Every physical vial of the BPC-157 (5mg) + TB-500 (5mg) Wolverine Blend manufactured by PX1 Research features an alphanumeric lot number printed directly on the primary label and secondary packaging. This unique identifier links the physical product to its specific synthesis batch, purification run, and third-party analytical dataset. Locating and verifying this lot number is the first step in establishing chemical provenance for your laboratory protocols.
To locate the lot identifier, inspect the side panel of the crimped glass vial. The lot number is positioned adjacent to the expiration date and storage parameter indicators, clearly prefixed by 'LOT:' followed by a distinct series of letters and numbers (e.g., LOT-WVL-2024-08A). The same identifier is duplicated on the outer vial box and master shipping documentation to maintain chain-of-custody consistency across your laboratory inventory management systems.
If a label is obscured due to cryogenic storage or handling, refer to the packing slip included with your shipment or inspect the barcode scan data. Should any discrepancies arise between your received package documentation and the physical vial, researchers are encouraged to halt experimental deployment and contact our analytical support team via our wholesale and laboratory account channel for immediate lot verification.
Step-by-Step Guide: Accessing Certificate of Analysis Data
Retrieving the specific Certificate of Analysis (COA) for your Wolverine Blend lyophilisate requires only a few standard steps. PX1 Research hosts a searchable, indexed database containing full high-resolution analytical reports for all active and historical lots. This infrastructure allows principal investigators and lab managers to archive analytical documentation prior to executing experimental protocols.
Begin by navigating to the official PX1 COA library. Once on the portal, locate the dedicated search interface and enter the precise alphanumeric sequence printed on your vial label. The system will filter our certified records and return the direct PDF report generated by an independent, ISO 17025-accredited testing facility. Alternatively, researchers may browse by compound category or product name to review historical lot consistency.
Upon opening the PDF document, verify that the lot number displayed in the header matches your physical product. The COA provides comprehensive data sections detailing physical appearance, solubility, HPLC purity integration, mass verification via electrospray ionization mass spectrometry (ESI-MS), and bacterial endotoxin testing. We recommend downloading and archiving this document alongside your lab notebooks and electronic health and safety (EHS) compliance records.
Deconstructing the Wolverine Blend COA: HPLC Quantitative Analysis
High-Performance Liquid Chromatography (HPLC) is the gold standard method for determining the chemical purity and relative concentration of synthetic peptides. For a dual-compound formulation such as the Wolverine Blend, HPLC analysis is particularly crucial. It must demonstrate not only high total purity but also clear chromatographic resolution between the two distinct peptide chains: BPC-157 (a 15-amino acid pentadecapeptide) and TB-500 (an N-terminal acetylated 17-amino acid active fragment of Thymosin Beta-4).
When examining the HPLC section of your Wolverine Blend COA, you will observe a reverse-phase chromatogram plotting retention time (in minutes) against absorbance (in milli-absorbance units, mAU) typically measured at a wavelength of 214 nm or 220 nm. In a co-lyophilized formulation, two dominant, well-resolved analytical peaks should be present. The area under the curve (AUC) for each peak is calculated to confirm that both peptide constituents meet our strict purity threshold of ≥98.0%.
Extraneous minor peaks representing truncated sequences, baseline noise, or deletion peptides from the solid-phase synthesis process are integrated and quantified. If any single impurity exceeds 0.5%, or if total impurities exceed 2.0%, the entire synthesis lot is rejected. Reviewing this chromatographic resolution ensures that your target assays are not confounded by uncharacterized peptide fragments.
Mass Spectrometry (MS) and Structural Identity Verification
While HPLC confirms chromatographic purity, Mass Spectrometry (MS) verifies structural identity by measuring the exact mass-to-charge ratio (m/z) of the synthesized molecules. Because different peptide sequences can theoretically share similar retention times under specific HPLC gradient conditions, mass analysis provides definitive confirmation that the vial contains intact BPC-157 and TB-500.
In the electrospray ionization mass spectrometry (ESI-MS) spectrum provided on the COA, researchers will find target mass peaks corresponding to the calculated monoisotopic or average molecular weights of both constituent compounds. BPC-157 possesses a theoretical molecular mass of approximately 1419.5 Da (C62H98N16O22), appearing as characteristic [M+H]+ and [M+2H]2+ ions. TB-500 (acetyl-LKKTETQ) exhibits a characteristic molecular mass profile corresponding to its specific sequence (typically ~4963.5 Da for the full-length active domain or its designated active fragment mass profile).
The spectral output must show sharp, unambiguous mass signals matching theoretical predictions within a strict tolerance window (±1.0 Da). The absence of unexplained mass adducts or signal degradation profiles guarantees that the peptides have maintained structural integrity throughout purification, co-formulation, and lyophilization processes.
Bacterial Endotoxin Testing and Bioburden Metrics
For researchers conducting delicate cell culture experiments, microfluidic tissue assays, or preclinical rodent models, bacterial endotoxin contamination poses a severe threat to data validity. Lipopolysaccharides (LPS) originating from Gram-negative bacterial outer membranes can trigger unwanted inflammatory cascades, alter macrophage expression profiles, and induce cell death in vitro, masking the true biological activity of the compound under study.
PX1 ResearchSubjects every lot of lyophilisate to formal Limulus Amebocyte Lysate (LAL) testing or recombinant Factor C (rFC) fluorometric assays. The resulting bioburden data is explicitly published on each COA. Our standards mandate that endotoxin levels remain below 0.05 EU/mg—significantly lower than standard commercial research grades.
Furthermore, our manufacturing facilities evaluate physical appearance, clarity upon reconstitution, and heavy metal content via ICP-MS. By reviewing the endotoxin metrics on your lot-specific certificate via our research documentation hub, principal investigators can proceed with sensitive biological assays confident that background inflammatory signals will not distort experimental outcomes.
Comparative Analysis: Dual-Peptide Syntheses vs. Single-Compound Controls
In comparative preclinical literature, researchers frequently evaluate the distinct biological pathways of multi-peptide blends against individual reference compounds. The combination of BPC-157 and TB-500 is often studied alongside other tissue-modulating and signal-transduction research peptides to observe differential cell signaling and receptor interaction metrics.
When designing comparative research protocols, investigators often run baseline controls using single-component preparations. For example, researchers may compare the cellular migration rates observed with the dual-peptide blend against individual isolates of BPC-157, TB-500, or independent remodeling peptides like GHK-Cu. Reviewing the individual COAs for each compound ensures that baseline concentrations and purity levels remain identical across all operational arms of the study.
Below is an overview comparing analytical verification requirements across standard research peptide categories:
Laboratory Reconstitution and Analytical Handling Parameters
Achieving consistent quantitative analytical results requires precise laboratory reconstitution procedures. Lyophilized peptide cakes must be handled under sterile laminar flow conditions using appropriate laboratory solvents, such as bacteriostatic water, sterile 0.9% sodium chloride, or specialized buffer solutions, depending on the requirements of your analytical assay.
To calculate exact volumetric concentrations and working dilution ratios for your reconstituted lyophilisate, utilize our interactive reconstitution calculator. Proper volumetric measurement ensures that both BPC-157 and TB-500 achieve their intended milligram-per-milliliter concentrations without inducing precipitation or concentration gradients within the stock solution.
Once reconstituted, solutions should be aliquoted into sterile, low-protein-binding microcentrifuge tubes to prevent repeated freeze-thaw cycles, which can induce peptide bond cleavage or aggregation. Stock solutions intended for short-term analytical work should be maintained at 2°C to 8°C, while long-term storage of reconstituted stock requires temperature regulation at -20°C or -80°C.
PX1 Quality Infrastructure: ISO 17025 and GMP-Compliant Synthesis
PX1 Research operates in strict alignment with rigorous manufacturing and analytical protocols. All synthetic sequences originate in modern, GMP-compliant synthesis facilities based in the USA. By utilizing automated solid-phase peptide synthesizers and high-efficiency purification columns, we achieve exceptional batch-to-batch consistency across our entire product catalog.
Our analytical verification relies exclusively on independent, ISO 17025-accredited testing laboratories. These independent facilities execute unblinded HPLC, ESI-MS, and LAL assays using standardized, validated testing methodologies. This firewall between synthesis and analytical testing guarantees that every COA published on our platform represents an objective, unmanipulated assessment of chemical quality.
Whether your laboratory requires single vials for initial pilot studies or large-scale consistent lots for long-term research projects, PX1 provides the supply chain stability and analytical transparency necessary for rigorous scientific inquiry. We invite researchers to explore our complete catalog of USA-manufactured compounds and experience the PX1 analytical standard.
Frequently Asked Questions
How do I match the lot number on my Wolverine Blend vial to the digital COA?
Locate the alphanumeric code printed after 'LOT:' on the side label of your vial or external box packaging. Navigate to the PX1 COA Lookup portal at /coa and enter this exact code to retrieve the matching PDF report.
What analytical methods are used to verify both BPC-157 and TB-500 in a single blend?
PX1 utilizes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) with dual-peak integration to verify the purity and ratio of both peptides, alongside Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm structural mass identity for both sequences.
Why is bacterial endotoxin testing essential for laboratory research compounds?
Endotoxins (lipopolysaccharides) can induce non-specific inflammatory responses in cellular assays and animal models, confounding experimental data. PX1 guarantees endotoxin levels below 0.05 EU/mg for verified research safety.
What purity threshold does PX1 Research require for lot release?
Every production lot of the Wolverine Blend must achieve a minimum chromatographic purity of ≥98.0% via HPLC analysis. Lots failing to meet this threshold are systematically rejected.
Where can I find COAs for other peptides in the PX1 catalog?
All COAs for PX1 compounds are indexed in our centralized repository at /coa. You can search by lot number or product name across our full research catalog.
How should lyophilized Wolverine Blend be stored prior to laboratory use?
Unopened, lyophilized vials should be stored in a dry, dark environment at -20°C for long-term stability. Allow the vial to warm to room temperature before reconstitution to prevent moisture condensation.
How does dual-peak HPLC integration work for multi-peptide formulations?
In RP-HPLC, BPC-157 and TB-500 elute at distinct retention times based on their specific hydrophobic properties. The chromatogram displays two separate, measurable peaks, allowing independent integration of chemical purity for each peptide.
Can my institution request raw raw analytical data files or custom lot documentation?
Yes. Principal investigators and institutional buyers requiring raw HPLC chromatogram integration data or custom lot verification can submit a request through our laboratory account portal at /wholesale.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.